Cocrystal Pharma, Inc. (COCP) Misses Q2 EPS by 21c

Cocrystal Pharma, Inc. (NASDAQ: COCP) reported Q2 EPS of ($0.25), $0.21 worse than the analyst estimate of ($0.04).

For earnings history and earnings-related data on Cocrystal Pharma, Inc. (COCP) click here.

You May Also Be Interested In

• New leader board: Citi refreshes AI compute semiconductor picks
• KLA Corporation (KLAC) PT Raised to $325 at Cantor Fitzgerald: Limited EPS Upside
• Rocket Lab to acquire Iridium in $8 billion cash-and-stock deal